Bandingkan Harga & Kinerja Putra Mandiri Jembar Tbk. (PMJS) vs Organon Pharma Indonesia Tbk. (SCPI)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan Putra Mandiri Jembar Tbk. dan Organon Pharma Indonesia Tbk.: Putra Mandiri Jembar Tbk. diperdagangkan di Rp143 (kapitalisasi pasar 2,01 T, volume 24 jam 1,63 jt), sedangkan Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M). Perbedaan utamanya: Putra Mandiri Jembar Tbk. jauh lebih besar — sekitar 19,3× kapitalisasi pasar Organon Pharma Indonesia Tbk.. Mana yang lebih baik tergantung tujuan investasimu.
| PMJS | SCPI | |
|---|---|---|
Kapitalisasi Pasar | 2,01 T | 104,4 M |
Volume | 1,63 jt | — |
Lot | 16,34 rb | — |
Perputaran | 235,47 jt | — |
Harga Rata-rata | 144,09 | — |
Nilai Transaksi | 235,47 jt | — |
Harga Ekuilibrium Indikatif | 143 | — |
Volume Ekuilibrium Indikatif | 678 | — |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang Putra Mandiri Jembar Tbk.
PT Putra Mandiri Jembar Tbk (the Company) was domiciled in Jakarta, established under the Deed No. 52 dated 18 July 2003 by notary Arikanti Natakusumah, S.H. PT Pahalamas Sejahtera is the parent entity and ultimate holding of the Company.
Selengkapnya di halaman PMJS →Tentang Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Selengkapnya di halaman SCPI →
